Five things for pharma marketers to know: Thursday, September 10, 2015

Cardiologists say that up to 15% of their patients could be on PCSK9 inhibitors next year; FDA committee to evaluate new Oxycodone version

from Most popular articles from Medical Marketing and Media http://ift.tt/1KbFgd2